What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Psychiatry
Physical therapy, Neuropathic pain, Anesthesia, Complex regional pain syndrome and Lidocaine are his primary areas of study.
His study of Chronic pain is a part of Physical therapy.
His study focuses on the intersection of Chronic pain and fields such as Clinical trial with connections in the field of Distress, Placebo-controlled study and Low back pain.
His work on Neuralgia as part of general Neuropathic pain research is frequently linked to Clinical Practice, thereby connecting diverse disciplines of science.
His Complex regional pain syndrome study combines topics in areas such as Vasomotor, Neglect and Edema.
The various areas that Bradley S. Galer examines in his Lidocaine study include Analgesic, Local anesthetic and Postherpetic neuralgia.
His most cited work include:
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. (2788 citations)
- Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations (1053 citations)
- Core outcome domains for chronic pain clinical trials (755 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Anesthesia, Neuropathic pain, Physical therapy, Analgesic and Lidocaine.
His Anesthesia course of study focuses on Placebo and Oxymorphone, Randomized controlled trial and Visual analogue scale.
The Neuropathic pain study combines topics in areas such as Peripheral neuropathy, Prospective cohort study and Clinical trial.
His Physical therapy research incorporates themes from Pain assessment, Physical medicine and rehabilitation and Low back pain.
His Analgesic research is multidisciplinary, incorporating perspectives in Brief Pain Inventory, Acetaminophen and Pain ladder, Opioid.
His Lidocaine research includes elements of Local anesthetic and Chemotherapy.
He most often published in these fields:
- Anesthesia (57.45%)
- Neuropathic pain (29.79%)
- Physical therapy (26.95%)
What were the highlights of his more recent work (between 2017-2021)?
- Dravet syndrome (12.06%)
- Anesthesia (57.45%)
- Stiripentol (4.96%)
In recent papers he was focusing on the following fields of study:
Bradley S. Galer focuses on Dravet syndrome, Anesthesia, Stiripentol, Open label and Extension study.
Bradley S. Galer has researched Dravet syndrome in several fields, including Clinical trial, Tolerability, Convulsive seizure, Effective dose and Pediatrics.
His studies deal with areas such as S syndrome, Convulsive Seizures and Placebo-controlled study as well as Anesthesia.
His study looks at the intersection of Placebo-controlled study and topics like Photosensitive epilepsy with Randomized controlled trial.
The study incorporates disciplines such as Concomitant and Placebo in addition to Stiripentol.
His work carried out in the field of Placebo brings together such families of science as Treatment resistant and Dose.
Between 2017 and 2021, his most popular works were:
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial (57 citations)
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial. (33 citations)
- A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome. (33 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Psychiatry
His main research concerns Dravet syndrome, Anesthesia, Stiripentol, Adverse effect and Fenfluramine Hydrochloride.
His research in Dravet syndrome intersects with topics in Placebo and Randomized controlled trial.
His Placebo study integrates concerns from other disciplines, such as Intention-to-treat analysis, Dose, Photosensitive epilepsy, Treatment resistant and Pediatrics.
Randomized controlled trial connects with themes related to Placebo-controlled study in his study.
He has included themes like Tolerability, Pulmonary hypertension and Seizure types in his Anesthesia study.
His Tolerability research incorporates elements of Clinical trial, Lennox–Gastaut syndrome, Epilepsy syndromes, Epilepsy and Concomitant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
